2-(5-Methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanamine

Catalog No. :
ACXAZZ864
CAS No. :
925154-89-8
Molecular Formula :
C7H10F3N3
Molecular Weight :
193.17

IUPAC Name:2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethan-1-amine

2-(5-Methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00Login to see priceInquiryInquiry
1g95%$252.00Login to see priceInquiryInquiry
5g95%$717.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-Methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethanamine
IUPAC Name2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethan-1-amine
MDL No.MFCD04967724
Molecular FormulaC7H10F3N3
Molecular Weight193.17
SMILESFC(C1=NN(CCN)C(C)=C1)(F)F
InChI KeySHUCOXQGYVIPDK-UHFFFAOYSA-N
SynonymART-CHEM-BB B016663;AKOS PAO-0984;AKOS B016663;2-[5-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ETHANAMINE;2-(5-METHYL-3-TRIFLUOROMETHYL-PYRAZOL-1-YL)-ETHYLAMINE;2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanamine(SALTDATA: FREE);1H-Pyrazole-1-ethanamine, 5-methyl-3-(trifluoromethyl)-
CAS No.925154-89-8

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H315-H318-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXAZZ864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXAZZ864 route product structure diagram
    ACXAZZ864925154-89-8
Inquiry

2. ACXAZZ864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXAZZ864 route product structure diagram
    ACXAZZ864925154-89-8
Inquiry

Comments (0)